The global leader in USAN/INN naming, partnering on 76% of USAN and 78% of INN drug name approvals!

418
Healthcare Clients
3357
Total Healthcare Names
553
Oncology Names
CLIENTNAMECATEGORY
PHARMACYCLICSabexinostatOncology
ASTRAZENECAacalabrutinibOncology
ACERTA PHARMAacalabrutinibOncology
GILEADacalisibOncology
ACTINIUMactinium (225ac) lintuzumab satetraxetanOncology
ASTRAZENECAadavosertibOncology
ADAPTIMMUNEafamitresgene autoleucelOncology
ADAPTIMMUNEafamitresgene autoleucelOncology
PFIZERagatolimodOncology
SHIONOGI PHARMAalicdamotideOncology
TAKEDA PHARMACEUTICALSalisertibOncology
GILEADalobresibOncology
FIVE PRIMEalsevalimabOncology
FIVE PRIMEalsevalimabOncology
CHONG KUN DANGalteminostatOncology
Bristol-Myers SquibbalvespimycinOncology
Bristol-Myers Squibbalvespimycin hydrochlorideOncology
SANOFIamcenestrantOncology
SANOFIamcenestrantOncology
JANSSENamivantamabOncology
CELGENEamrubicin hydrochlorideOncology
GILEADandecaliximabOncology
JANSSENapalutamideOncology
BAYERaprutumabOncology
BAYERaprutumab ixadotinOncology
ISOFOLarfolitixorinOncology
BIOSIGHTaspacytarabineOncology
GLAXOSMITHKLINEastuprotimut-rOncology
SHIONOGI PHARMAasudemotideOncology
GENENTECHatezolizumabOncology
GENENTECHautogene cevumeranOncology
GENENTECHautogene cevumeranOncology
BASILEA PHARMACEUTICALSavanbulinOncology
BLUEPRINT MEDICINESavapritinibOncology
ADVAXISaxalimogene filolisbacOncology
SYNDAXaxatilimabOncology
ABBVIEazintuxizumabOncology
ABBVIEazintuxizumab vedotinOncology
IMMUNE DESIGNbaloramotideOncology
GlaxoSmithKlinebelantamabOncology
GlaxoSmithKlinebelantamab mafodotinOncology
SPECTRUM PHARMACEUTICALSbelinostatOncology
GLAXOSMITHKLINEbelizatinibOncology
HANMI PHARMACEUTICALSbelvarafenibOncology
MERCK & CO.belzutifanOncology
FIVE PRIME THERAPEUTICSbemarituzumabOncology
BERGEN BIObemcentinibOncology
NEKTARbempegaldesleukinOncology
BioInvent InternationalbersanlimabOncology
VERTEX PHARMACEUTICALSberzosertibOncology
AMGENbevacizumab betaOncology
ASTRAZENECAbicalutamideOncology
PIQURbimiralisibOncology
Inoviobizalimogene ralaplasmidOncology
MEDIMMUNEblinatumomabOncology
ONCOMEDbrontictuzumabOncology
ABBVIEbudigalimabOncology
FIVE PRIME THERAPEUTICScabiralizumabOncology
EXELIXIScabozantinibOncology
IMMUNE DESIGNcadalimogene ixalentivecOncology
ADC THERAPEUTICScamidanlumabOncology
ADC THERAPEUTICScamidanlumab tesirineOncology
MONOPARcamsirubicinOncology
TAKARA BIOcanerpaturevOncology
IMMUNOGENcantuzumab ravtansineOncology
ASTRAZENECAcapivasertibOncology
ADVAXIScapolimogene apralisbacOncology
JOHNSON & JOHNSONcarlumabOncology
TRACON PHARMACEUTICALScarotuximabOncology
AstexcedazuridineOncology
ASTRAZENECAceralasertibOncology
PORTOLAcerdulatinibOncology
JanssencetrelimabOncology
GENENTECHcevostamabOncology
JANSSENciltacabtagene autoleucelOncology
PIERIS PHARMACEUTICALScinrebafusp alfaOncology
LYCERAcintirorgonOncology
GENENTECHcobimetinibOncology
BAYERcopanlisibOncology
CHECKPOINT THERAPEUTICScosibelimabOncology
ADUROdamistimagene matitucelOncology
ASTRAZENECAdanvatirsenOncology
JANSSENdaratumumabOncology
BAYERdarolutamideOncology
DAIICHI-SANKYOdatopotamabOncology
DAIICHI-SANKYOdatopotamab deruxtecanOncology
CERULEANdavamotecan pegadexamerOncology
ONCOMEDdemcizumabOncology
NANOCARRIERdemplatin pegraglumerOncology
SEATTLE GENETICSdenintuzumab mafodotinOncology
ABBVIEdepatuxizumabOncology
ABBVIEdepatuxizumab mafodotinOncology
ARQULEderazantinibOncology
ARQULEderazantinib hydrochlorideOncology
RAFAEL PHARMACEUTICALSdevimistatOncology
APOTEXdocetaxelOncology
CANTEX PHARMACEUTICALSdociparstatOncology
NOVARTISdovitinibOncology
NOVARTISdovitinib lactateOncology
GENENTECHdulanerminOncology
GENENTECHduligotuzumabOncology
JANSSENduvortuxizumabOncology
ONCOMEDefaprinermin alfaOncology
MEDIMMUNEefgivanermin alfaOncology
Genexineefineptakin alfaOncology
ABBVIEeftozanermin alfaOncology
RADIUS HEALTHelacestrantOncology
SYNTA PHARMACEUTICALSelesclomolOncology
ABBVIEelotuzumabOncology
ONCOTHERAPY SCIENCEelpamotideOncology
AGIOSenasidenibOncology
ABBOTT LABORATORIESenavatuzumabOncology
GLAXOSMITHKLINEencelimabOncology
ATHENEXencequidarOncology
SEATTLE GENETICSenfortumab vedotinOncology
ADUROenistimagene setitucelOncology
XCOVERYensartinibOncology
NEOGENIX ONCOLOGYensituximabOncology
GILEADentospletinibOncology
IGNYTAentrectinibOncology
MEDIVATIONenzalutamideOncology
SHIONOGI PHARMAepertinibOncology
MEDIMMUNEetaracizumabOncology
OnxeoetidaligideOncology
OncoMedetigilimabOncology
NEKTARetirinotecan pegolOncology
NEKTARetirinotecan pegol tetrahydrochlorideOncology
NEKTARetirinotecan pegol tetratriflutateOncology
EMD SERONOevobrutinibOncology
SANOFIfedratinibOncology
GLAXOSMITHKLINEfeladilimabOncology
STEMLINE THERAPEUTICSfelezonexorOncology
MORPHOSYSfelzartamabOncology
NIPPON KAYAKUfirtecan peglumerOncology
BLUEPRINT MEDICINESfisogatinibOncology
SIEMENSflortanidazole (18f)Oncology
SIEMENSflotegatide (18f)Oncology
MAST THERAPEUTICSfolitixorinOncology
MAST THERAPEUTICSfolitixorin calciumOncology
OXIGENEfosbretabulinOncology
OXIGENEfosbretabulin disodiumOncology
OXIGENEfosbretabulin tromethamineOncology
BIONOVUS LIFE SCIENCESfosciclopiroxOncology
NUCANAfosgemcitabine palabenamideOncology
NUCANAfosifloxuridine nafalbenamideOncology
TAIRXfoslinanibOncology
GLYCOTOPEgatipotuzumabOncology
SANOFI GENZYMEgatralimabOncology
PFIZERgemtuzumab ozogamicinOncology
ABBVIEgiloralimabOncology
ASTELLASgilteritinibOncology
MIRATI THERAPEUTICSglesatinibOncology
ASTEXguadecitabineOncology
PHARMACYCLICSibrutinibOncology
GILEADidelalisibOncology
ABBVIEilorasertibOncology
SHIRE PHARMACEUTICALSimalumabOncology
ROCHEimgatuzumabOncology
PHOSPLATIN THERAPEUTICSimifoplatinOncology
TAKEDA PHARMACEUTICALSindusatumabOncology
TAKEDA PHARMACEUTICALSindusatumab vedotinOncology
LUNDBECK INC.ingenol disoxateOncology
BIPARiniparibOncology
BIOCANCELL THERAPEUTICSinodiftagene vixteplasmidOncology
JOHNSON & JOHNSONintetumumabOncology
ACTINIUMiodine (131i) apamistamabOncology
ONCOMEDipafriceptOncology
GENENTECHipatasertibOncology
SANOFIisatuximabOncology
AGIOSivosidenibOncology
TAKEDA PHARMACEUTICALSixazomibOncology
SEATTLE GENETICSladiratuzumabOncology
SEATTLE GENETICSladiratuzumab vedotinOncology
IMMUNE DESIGNlapretolimodOncology
IMMUNOGENlaprituximabOncology
IMMUNOGENlaprituximab emtansineOncology
DENDREONlapuleucel-tOncology
VIONlaromustineOncology
LOXO ONCOLOGYlarotrectinibOncology
ONCOTHERAPY SCIENCElatromotideOncology
MOLOGENlefitolimodOncology
ADAPTIMMUNEletetresgene autoleucelOncology
YM BIOSCIENCESlexibulinOncology
Iovance BIOTHERAPEUTICSlifileucelOncology
BEIGENElifirafenibOncology
ABBVIElinifanibOncology
OSI PHARMACEUTICALSlinsitinibOncology
BASILEA PHARMACEUTICALSlisavanbulinOncology
JW THERAPEUTICSlisocabtagene maraleucelOncology
ADC THERAPEUTICSloncastuximabOncology
ADC THERAPEUTICSloncastuximab tesirineOncology
JANSSENlorpucitinibOncology
APEIRONlorukafusp alfaOncology
IMMUNOGENlorvotuzumab mertansineOncology
NOVARTISlucatumumabOncology
FORTY SEVENmagrolimabOncology
Inoviomavilimogene ralaplasmidOncology
X4mavorixaforOncology
ONCOPEPTIDESmelphalan flufenamideOncology
SYROSmevociclibOncology
DAIICHI-SANKYOmilademetanOncology
TAKARA BIOmipetresgene autoleucelOncology
INSPYR TherapeuticsmipsagarginOncology
ARQULEmiransertibOncology
IMMUNOGENmirvetuximab soravtansineOncology
ABBVIEmirzotamabOncology
ABBVIEmirzotamab clezutoclaxOncology
JANSSENmitazalimabOncology
TAKEDAmivavotinibOncology
TAKEDAmobocertinibOncology
MIRATI THERAPEUTICSmocetinostatOncology
MIRATI THERAPEUTICSmocetinostat dihydrobromideOncology
GLAXOSMITHKLINEmolibresibOncology
EnzyChemmosedipimodOncology
GENENTECHmosunetuzumabOncology
BIOLINEmotixafortideOncology
MEDIMMUNEmoxetumomab pasudotoxOncology
AMGENmurizatoclaxOncology
GAMAMABSmurlentamabOncology
IMMUNOGENnaratuximab emtansineOncology
ONCOMEDnavicixizumabOncology
ONCOMEDnavicixizumabOncology
ABBVIEnavitoclaxOncology
CHECKPOINT THERAPEUTICSolafertinibOncology
ADAPTIMMUNEolitresgene autoleucelOncology
HANMI PHARMACEUTICALSolmutinibOncology
CEPHALONomacetaxine mepesuccinateOncology
GLAXOSMITHKLINEomipalisibOncology
CELGENEonatasertibOncology
CELGENEonatasertibOncology
JanssenonvatilimabOncology
JANSSENopolimogene capmilisbacOncology
AMGENoprozomibOncology
TAKEDA PHARMACEUTICALSorteronelOncology
CELGENEorvacabtagene autoleucelOncology
GERONpaclitaxel trevatideOncology
CYTOMX THERAPEUTICSpacmilimabOncology
BEIGENEpamiparibOncology
DAIICHI-SANKYOpatritumabOncology
JAZZ PHARMACEUTICALSpegcrisantaspaseOncology
AVELAS BIOSCIENCESpegloprastideOncology
HALOZYME THERAPEUTICSpegvorhyaluronidase alfaOncology
AEGLEA BIOTHERAPEUTICSpegzilarginaseOncology
ASCENTAGE PHARMApelcitoclaxOncology
MERCK & CO.pembrolizumabOncology
IncytepemigatinibOncology
JANSSENpemlimogene merolisbacOncology
JENNEREXpexastimogene devacirepvecOncology
DAIICHI-SANKYOpexidartinibOncology
SANOFIpilaralisibOncology
GENENTECHpinatuzumab vedotinOncology
EPIZYMEpinometostatOncology
GENENTECHpolatuzumab vedotinOncology
CELGENEpomalidomideOncology
ARIADponatinibOncology
ARIADponatinib hydrochlorideOncology
HANMI PHARMACEUTICALSposeltinibOncology
ONCOTHERAPY SCIENCEpradimotideOncology
BLUEPRINT MEDICINESpralsetinibOncology
CYTOMX THERAPEUTICSpraluzatamabOncology
CYTOMX THERAPEUTICSpraluzatamab ravtansineOncology
BIO-PATH HOLDINGSprexigebersenOncology
JOHNSON & JOHNSONquisinostatOncology
BAYERradretumabOncology
BAYERrefametinibOncology
4SCresminostatOncology
ABBVIErevdofilimabOncology
BETA PHARMArezivertinibOncology
ACETYLONricolinostatOncology
BELLICUM PHARMACEUTICALSrimiducidOncology
LSK BIOPHARMArivoceranibOncology
ABBVIErizankizumabOncology
CLOVIS ONCOLOGYrociletinibOncology
ABBVIErolinsatamabOncology
ABBVIErolinsatamab talirineOncology
BAYERroniciclibOncology
SYNTA PHARMACEUTICALSrosabulinOncology
ONCOMEDrosmantuzumabOncology
TELIX PHARMACEUTICALSrosopatamabOncology
TELIX PHARMACEUTICALSrosopatamab tetraxetanOncology
STEMCENTRXrovalpituzumabOncology
STEMCENTRXrovalpituzumab tesirineOncology
LYTIXruxotemitideOncology
AbbViesamrotamabOncology
AbbViesamrotamab vedotinOncology
TAKEDA PHARMACEUTICALSsapanisertibOncology
OCTAPHARMA ABsatoreotideOncology
IPSEN BIOPHARM LTDsatoreotide tetraxetanOncology
OCTREOPHARMsatoreotide trizoxetanOncology
ASTRAZENECAsavolitinibOncology
SalariusseclidemstatOncology
KARYOPHARMselinexorOncology
LOXO ONCOLOGYselitrectinibOncology
LOXO ONCOLOGYselpercatinibOncology
JANSSENseltorexantOncology
ASTRAZENECAselumetinibOncology
ASTRAZENECAselumetinib sulfateOncology
TAKEDA PHARMACEUTICALSserabelisibOncology
ABBVIEserclutamabOncology
ABBVIEserclutamab talirineOncology
JOHNSON & JOHNSONserdemetanOncology
SANOFIseribantumabOncology
INNOCRIN PHARMACEUTICALSseviteronelOncology
JOHNSON & JOHNSONsiltuximabOncology
GILEADsimtuzumabOncology
TAKEDAsimurosertibOncology
DENDREONsipuleucel-tOncology
AMGENsitravatinibOncology
Cascadian TherapeuticssonolisibOncology
BAYERsorafenibOncology
ONCOTHERAPYSCIENCEtabituximabOncology
ONCOTHERAPYSCIENCEtabituximab barzuxetanOncology
MORPHOSYStafasitamabOncology
JANSSENtalacotuzumabOncology
BIOMARINtalazoparibOncology
JOHNSON & JOHNSONtalmapimodOncology
JANSSENtalquetamabOncology
ABBVIEtamrintamabOncology
ABBVIEtamrintamab pamozirineabOncology
AMGENtapotoclaxOncology
ONCOMEDtarextumabOncology
THRESHOLD PHARMACEUTICALStarloxotinib bromideOncology
DNATRIX THERAPEUTICStasadenoturevOncology
GENENTECHtaselisibOncology
OncoSectavokinogene telseplasmidOncology
EPIZYMEtazemetostatOncology
TAKARA BIOtebrocabtagene autoleucelOncology
JANSSENteclistamabOncology
BetaCattegavivintOncology
CALITHERAtelaglenastatOncology
GLENMARK PHARMACEUTICALStelazorlimabOncology
ABBVIEtelisotuzumabOncology
ABBVIEtelisotuzumab vedotinOncology
AstraZenecatelratolimodOncology
ERIMOS PHARMACEUTICALSterameprocolOncology
ISOTECHNIKAterameprocolOncology
ABYDERMtezatabep matraxetanOncology
IDERA PHARMACEUTICALStilsotolimodOncology
BERGEN BIOtilvestamabOncology
GLYCOTOPEtimigutuzumabOncology
MUNDIPHARMAtinostamustineOncology
GILEADtirabrutinibOncology
GENENTECHtiragolumabOncology
ATHENEXtirbanibulinOncology
GENEXINEtirvalimogene teraplasmidOncology
NOVARTIStisagenlecleucelOncology
BEIGENEtislelizumabOncology
DAIICHI-SANKYOtivantinibOncology
EffectortomivosertibOncology
GLYCOTOPEtomuzotuximabOncology
BLAZE BIOSCIENCEtozuleristideOncology
AMGENtrebananibOncology
SHIONOGI PHARMAtrempamotideOncology
Cascadian TherapeuticstucatinibOncology
BIOMED VALLEYulixertinibOncology
GLAXOSMITHKLINEuprosertibOncology
SURFACE ONCOLOGYurabrelimabOncology
JUNO THERAPEUTICSvadacabtagene leraleucelOncology
CELGENEvadacabtagene leraleucelOncology
SEATTLE GENETICSvadastuximabOncology
SEATTLE GENETICSvadastuximab talirineOncology
CHONG KUN DANGvalecobulinOncology
ONCOMEDvantictumabOncology
SUNESIS PHARMACEUTICALSvecabrutinibOncology
INTREXONveledimexOncology
ABBVIEveliparibOncology
ABBVIEvenetoclaxOncology
MYRIADverubulinOncology
GILEADvesatolimodOncology
JouncevopratelimabOncology
AGIOSvorasidenibOncology
AGIOSvorasidenib citrateOncology
TYROGENEXvorolanibOncology
SEATTLE GENETICSvorsetuzumab mafodotinOncology
SUNESIS PHARMACEUTICALSvosaroxinOncology
RADIUS HEALTHvosilasarmOncology
SANOFIvoxtalisibOncology
MEI PHARMAzandelisibOncology
ZYMEWORKSzanidatamabOncology
BEIGENEzanubrutinibOncology
GLAXOSMITHKLINEzastumotideOncology
ASTELLASzolbetuximabOncology
EFFECTORzotatifinOncology